Inflammatory bowel disease often affects women during their reproductive years and their treatment causes concerns for both physicians and the patient. Apart from methotrexate, most drugs used regularly to treat ulcerative colitis and Crohn's disease can safely be used by pregnant women. A multidisciplined approach involving both obstetrician and gastroenterologist and the education of the patient are essential components of the treatment of any young women with inflammatory bowel disease.
Foetal risks related to inflammatory bowel disease treatment during pregnancy,Rischi per il feto legati alla terapia delle malattie infiammatorie croniche intestinali durante la gravidanza
Ferrero, S.;
2003-01-01
Abstract
Inflammatory bowel disease often affects women during their reproductive years and their treatment causes concerns for both physicians and the patient. Apart from methotrexate, most drugs used regularly to treat ulcerative colitis and Crohn's disease can safely be used by pregnant women. A multidisciplined approach involving both obstetrician and gastroenterologist and the education of the patient are essential components of the treatment of any young women with inflammatory bowel disease.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
